The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study

Journal of Neurochemistry

Volumn 55, Issue 5, 1990, Pages 1734-1740

  Spanagel, Rainer ^a   Herz, Albert ^a   Shippenberg, Toni S ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Dopamine metabolism; Dopamine release in vivo; Intracerebral microdialysis; Nucleus accumbens; Opioids; Reward

Indexed keywords

ENKEPHALIN DERIVATIVE; OPIATE;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE RELEASE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMAL; DIALYSIS; DOPAMINE; DYNORPHINS; ENDORPHINS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; INJECTIONS, INTRAVENTRICULAR; MAGNESIUM; MALE; NUCLEUS ACCUMBENS; PEPTIDE FRAGMENTS; POTASSIUM; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; TETRODOTOXIN;

ANIMALIA;

EID: 0025107375     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1990.tb04963.x     Document Type: Article

References (30)

1. Evidence that the aversive effects of opioid antagonists and kappa agonists are centrally mediated
2. Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β‐endorphin in the rat
3. An in vivo voltammetric analysis of dopamine release in the nucleus accumbens: I. Morphine effects. II. Cocaine effects
4. Dynorphin is a specific endogenous ligand of the kappa opioid receptor
5. Studies in vivo with ICI 174, 864 and DPDPE
6. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
7. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
8. Drugs and reinforcement mechanisms: a critical review of the catecholamine theory
9. 3H]CTOP), a potent and highly selective peptide for mu receptors in rat brain
10. Positive reinforcement properties of drugs: search for neural substrate
11. Modulation of dopamine release in rat striatal slices by delta‐opiate agonists
12. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning
13. Anatomy of CNS opioid receptors
14. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
15. Chemical tools in the study of excitable membranes
16. Further evidence for a role of delta opiate‐receptors in the presynaptic regulation of newly synthesized do‐pamine release
17. Depression of morphine‐seeking behaviour by dopamine inhibition
18. Motivational effects of opioids: influence of D‐1 versus D‐2 receptor antagonists
19. Motivational properties of opioids: evidence that an activation of delta receptors mediates reinforcement processes
20. Endogenous opioids and reinforcement: role of multiple opioid receptor types and dopamine
21. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
22. Nucleus ac‐cumbens opiate‐dopamine interactions and locomotor activation in the rat: evidence for a presynaplic locus
23. Nor‐binaltorphimine, a highly selective kappa opioid antagonist in analgesic and receptor binding assays
24. Rapid postmortem increase in extracellular dopamine in the rat brain as assessed by brain microdialysis
25. The use of tetrodotoxin for the characterisation of drug‐enhanced dopamine release in conscious rats studied by brain dialysis
26. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis
27. Brain neuronal systems mediating reward processes
28. Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3‐methoxytyramine measurements
29. Effects of delta and mu opi‐opeptides on the turnover and release of dopamine in rat stria‐turn